Celero Systems
Brookline, US · Founded 2017 · 1 known investors
Find your way into Celero Systems
Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires. It operates in the digital health and medical device space.
Founders & leadership
XH
Xin HuangNamed on SEC filing
BP
Benjamin PlessNamed on SEC filing
CG
Carlo Giovanni TraversoNamed on SEC filing
AM
Allan MayNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2019
▶$3MraisedJul 2019 · 5 investors · OtherRule 506(b)
▶$3MraisedJul 2019 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Xin HuangDirector
- Benjamin PlessExecutive Officer, Director
- Carlo Giovanni TraversoDirector
- Allan MayDirector
- Offering amount
- $3.5M
- Amount sold
- $3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Celero Systems do?
- Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires. It operates in the digital health and medical device space.
- Who are Celero Systems's investors?
- Celero Systems's investors include Foothill Ventures.
- How much funding has Celero Systems raised?
- Celero Systems has disclosed $3M raised across 1 round.
- Where is Celero Systems headquartered?
- Celero Systems is headquartered in Brookline, US.